Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17287478 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.